Children who received the vaccine developed virus-fighting antibodies similar to levels that young adults produce after full-strength shots, Moderna said.
said Monday that a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds, as the manufacturer moves toward expanding shots to children.
A health worker holds up a bottle of the Moderna COVID-19 vaccine. Moderna said Monday that a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds.Preliminary results showed vaccinated kids developed virus-fighting antibodies similar to levels that young adults produce after full-strength shots, Moderna said in a press release.
The study was too small to spot any extremely rare side effects, such as heart inflammation that sometimes occurs after either the Moderna or Pfizer vaccines, mostly among young men.Moderna said it plans to submit its pediatric data to the FDA and global regulators soon. The FDA hasn’t yet ruled on the company’s application to expand its vaccinations to 12- to 17-year-olds, although some countries have cleared Moderna’s shots for adolescents.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Moderna says its COVID-19 vaccine is protective, safe in kids 6 to 11Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and safety was comparable to what was previously seen in clinical trials of adolescents and adults.
Les mer »
Moderna says its low-dose COVID shot works for kids 6 to 11Moderna said Monday that a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds, as the manufacturer moves toward expanding shots to children. Competitor Pfizer's kid-sized vaccine doses are closer to widespread use, undergoing evaluation by the Food and Drug Administration for nearly the same age group — starting at age 5.
Les mer »
Moderna says its COVID-19 vaccine protective, safe in young childrenModerna Inc said on Monday its COVID-19 vaccine generated a strong immune response and was generally well-tolerated in children aged six to 11 years, and the company plans to submit the data to regulators soon.
Les mer »
Moderna says its Covid-19 vaccine was well-tolerated and generated robust immune response in children ages 6 to 11Interim results of a Phase 2/3 trial showed Moderna's Covid-19 vaccine was well-tolerated and generated a robust immune response in children ages 6 to 11, the company said Monday.
Les mer »
U.S. administers nearly 413 mln doses of COVID-19 vaccinesThe United States has administered 412,856,169 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 503,521,625 doses, the U.S. Centers for Disease Control and Prevention said.
Les mer »
U.S. has administered nearly 414 mln doses of COVID-19 vaccinesThe United States has administered 413,645,478 doses of COVID-19 vaccines in the country as of Sunday morning and distributed 503,493,015 doses, the U.S. Centers for Disease Control and Prevention said.
Les mer »